WELLINGTON MANAGEMENT GROUP LLP
Position in GPCR — Structure Therapeutics Inc.
CIK 902219
Boston, MA
Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$396,054,165
+$46,108,334 QoQ
Shares Held
7,379,433
+1.6% QoQ
Ownership
10.3%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2
of 190 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 89%
None 11%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. GPCR ranks #14 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in GPCR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $396,054,165 | 7,379,433 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $349,945,831 | 7,260,287 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $495,333,984 | 7,121,984 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $159,297,236 | 5,689,187 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $142,603,445 | 6,875,769 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $134,865,375 | 7,791,183 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $211,145,849 | 7,785,614 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $341,015,247 | 7,769,771 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $296,406,815 | 7,547,920 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $249,773,333 | 5,827,656 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $178,216,003 | 4,372,326 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $43,743,331 | 867,579 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,740,881 | 210,269 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,376,597 | 99,899 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||